TAS-116, an oral HSP90 inhibitor, in combination with nivolumab in patients with colorectal cancer and other solid tumors: An open-label, dose-finding, and expansion phase Ib trial (EPOC1704).
暂无分享,去创建一个
S. Nomura | A. Sato | H. Nishikawa | N. Yamamoto | K. Shitara | A. Kawazoe | H. Taniguchi | Y. Naito | Y. Kuboki | M. Wakabayashi | Mitsuko Suzuki | D. Kotani | K. Harano | M. Fukutani | H. Shima | Tsukiko Higuchi